A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men
Clinical trial NCT06631430 · COMPLETED
Trial details
- NCT number
- NCT06631430
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-30
- Primary completion
- 2025-06-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.